On ECHEMI
Home > Drugs > Qilu Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
  • Founded in:

    1992-08-21
  • Country:

    China China
  • Address:

    No. 317, Xinluo Street, High-tech Zone, Jinan City, Shandong Province
  • Tax NO.:

    91370000614073351Q
  • Registered Funds:

    600 million yuan
  • Website:

  • Email:

Related Drugs
Carboplatin
Carboplatin, Excipient name: Mannitol
Name Description Content CAS NO. Registered Holders
Carboplatin

41575-94-4 38
Mannitol

87-78-5 31
Mesna
Name Description Content CAS NO. Registered Holders
Mesna

Extract from the above information

More

Extract from the above information

19767-45-4 17
Zopiclone
Name Description Content CAS NO. Registered Holders
Zopiclone

Extract from the above information

More

Extract from the above information

0
Zopiclone tablets
The main ingredient of this product is zopiclone. Its chemical name is 6-(5-chloropyridin-2-yl)-7-[(4-methylpiperazine-1-yl)carbonyloxy]-5,6-dihydropyrrolo[3,4-b]pyrazine-5-one.
Name Description Content CAS NO. Registered Holders
Zopiclone

It has sedative, hypnotic and muscle relaxant effects. It acts on benzodiazepine receptors, but the binding mode is different from benzodiazepine drugs. It is a fast-acting hypnotic that can prolong sleep time, improve sleep quality, and reduce the number of night awakenings and early awakenings. It is characterized by low residual effect the next morning.

More

It has sedative, hypnotic and muscle relaxant effects. It acts on benzodiazepine receptors, but the binding mode is different from benzodiazepine drugs. It is a fast-acting hypnotic that can prolong sleep time, improve sleep quality, and reduce the number of night awakenings and early awakenings. It is characterized by low residual effect the next morning.

0
Zopiclone tablets
The main ingredient of this product is zopiclone. Chemical name: 6-(5-chloropyridin-2-yl)-7-[(4-methylpiperazine-1-yl)carbonyloxy]-5,6-dihydropyrrolo[3,4-b]pyrazin-5-one Molecular weight: C17H17ClN6O3
Name Description Content CAS NO. Registered Holders
Zopiclone

The specific pharmacological action description cannot be directly obtained from the above information.

More

The specific pharmacological action description cannot be directly obtained from the above information.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.